People with severe gastrointestinal (GI) disorders, such as gastroparesis or inflammatory bowel disease, should also avoid GLP-1 agonists due to the possibility of exacerbating GI symptoms (23)
Pregnant or nursing women, infants, young children, and minors should avoid consumption
Before receiving folic acid or cyanocobalamin, patients should be assessed for deficiency and appropriate therapy started concurrently
PCOS is a common endocrine glands-related disease affecting 5-10% of reproductive-age women
However, like any injectable treatment, it may carry some risks such as allergic reactions, injection site discomfort, or mild side effects like nausea